BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH
139 results:

  • 1. Status and trends of RGS16 based on data visualization analysis: A review.
    Wenbo L; Liangyu X; Zhiyong L; Gongchang Y; Yuanzhen C; Bin S
    Medicine (Baltimore); 2024 Feb; 103(7):e36981. PubMed ID: 38363937
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
    Eissa H; Thakar MS; Shah AJ; Logan BR; Griffith LM; Dong H; Parrott RE; O'Reilly RJ; Dara J; Kapoor N; Forbes Satter L; Chandra S; Kapadia M; Chandrakasan S; Knutsen A; Jyonouchi SC; Molinari L; Rayes A; Ebens CL; Teira P; Dávila Saldaña BJ; Burroughs LM; Chaudhury S; Chellapandian D; Gillio AP; Goldman F; Malech HL; DeSantes K; Cuvelier GDE; Rozmus J; Quinones R; Yu LC; Broglie L; Aquino V; Shereck E; Moore TB; Vander Lugt MT; Mousallem TI; Oved JH; Dorsey M; Abdel-Azim H; Martinez C; Bleesing JH; Prockop S; Kohn DB; Bednarski JJ; Leiding J; Marsh RA; Torgerson T; Notarangelo LD; Pai SY; Pulsipher MA; Puck JM; Dvorak CC; Haddad E; Buckley RH; Cowan MJ; Heimall J
    J Allergy Clin Immunol; 2024 Jan; 153(1):287-296. PubMed ID: 37793572
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A phase I/II study of the safety and efficacy of [
    Wild D; Grønbæk H; Navalkissoor S; Haug A; Nicolas GP; Pais B; Ansquer C; Beauregard JM; McEwan A; Lassmann M; Pennestri D; Volteau M; Lenzo NP; Hicks RJ
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):183-195. PubMed ID: 37721581
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia.
    Croucher PJP; Ridinger M; Becker PS; Lin TL; Silberman SL; Wang ES; Zeidan AM
    Ann Hematol; 2023 Nov; 102(11):3049-3059. PubMed ID: 37702821
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis.
    Behrouzi R; Armstrong AC; Howell SJ
    Breast Cancer Res Treat; 2023 Nov; 202(1):83-95. PubMed ID: 37584881
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Lung cancer with breast metastasis: a case report and review of the literature.
    Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
    J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.
    Bender L; Pflumio C; Trensz P; Pierard L; Kalish M; Fischbach C; Petit T
    Cancer Treat Res Commun; 2023; 36():100738. PubMed ID: 37390791
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Primary Ewing sarcoma of the lung: A systematic review of the recent literature.
    Fedeli MA; Marras V; Fara AM; Deiana A; Lobrano R; Cossu A; Paliogiannis P
    Ann Diagn Pathol; 2023 Aug; 65():152152. PubMed ID: 37149954
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Plasma hPG
    Prieur A; Harper A; Khan M; Vire B; Joubert D; Payen L; Kopciuk K
    BMC Cancer; 2023 Apr; 23(1):305. PubMed ID: 37016331
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Frailty in Patients with Chronic Graft-versus-Host Disease.
    Rashid N; Arora M; Jurdi NE; Onstad L; Pidala JA; Flowers ME; Lee SJ
    Transplant Cell Ther; 2023 Jun; 29(6):367-374. PubMed ID: 36921916
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Performance of the HAS-BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and cancer: Data From the French National Hospital Discharge Database.
    Pastori D; Marang A; Bisson A; Herbert J; Lip GYH; Fauchier L
    J Am Heart Assoc; 2022 Dec; 11(23):e026388. PubMed ID: 36444864
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney cancer Consortium (TKCC) Database.
    Yekedüz E; Karakaya S; Ertürk İ; Tural D; Uçar G; Şentürk Öztaş N; Arıkan R; Hızal M; Küçükarda A; Sever ÖN; Arslan Ç; Can O; Kılıçkap S; Yazgan C; Karadurmuş N; Şendur MA; Çiçin İ; Demirci U; Özgüroğlu M; Öksüzoğlu B; Ürün Y
    Clin Genitourin Cancer; 2023 Feb; 21(1):175-182. PubMed ID: 35970759
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [cancer survival during 2012-2018 in cancer registries of Shandong Province].
    Jiang F; Fu ZT; Lu ZL; Chu J; Guo XL; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):806-814. PubMed ID: 35785863
    [No Abstract]    [Full Text] [Related]  

  • 14. Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
    Gonçalves JM; Scarini JF; Gondak R; Altemani A; Mariano FV
    Oral Oncol; 2022 Mar; 126():105779. PubMed ID: 35183913
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy
    Miyamoto T; Sanford D; Tomuleasa C; Hsiao HH; Olivera LJE; Enjeti AK; Gimenez Conca A; Castillo TBD; Girshova L; Martelli MP; Guvenc B; Delgado A; Duan Y; Garbayo Guijarro B; Llamas C; Lee JH
    Leuk Lymphoma; 2022 Apr; 63(4):928-938. PubMed ID: 35147482
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of
    Metser U; Zukotynski K; Mak V; Langer D; MacCrostie P; Finelli A; Kapoor A; Chin J; Lavallée L; Klotz LH; Hagerty M; Hildebrand C; Bauman G
    Radiology; 2022 May; 303(2):414-422. PubMed ID: 35076300
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation.
    Kroesen M; Miladinovic V; Hutschemaekers SAJ; Jacobs J; van der Vos C; Wolf AL; Hoogeman MS; van Vulpen M; Bloem JL; P D S Dijkstra S; Peul WC; Penninkhof JJ; Krol ADG
    Radiother Oncol; 2022 Jan; 166():58-64. PubMed ID: 34843840
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Opioid prescriptions in bone metastatic cancer patients: A cross sectional nationwide pharmacoepidemiological study].
    Tarot A; Delorme J; Authier N; Guastella V
    Bull Cancer; 2021 Dec; 108(12):1120-1125. PubMed ID: 34688483
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multimorbidity networks associated with frailty among middle-aged and older people with HIV.
    Lorenz DR; Mukerji SS; Misra V; Uno H; Gelman BB; Moore DJ; Singer EJ; Morgello S; Gabuzda D
    AIDS; 2021 Dec; 35(15):2451-2461. PubMed ID: 34324449
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Skull Base Tumors: Neuropathology and Clinical Implications.
    Bi WL; Santagata S
    Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.